Literature DB >> 6534457

Antisperm antibodies and male infertility.

M Upadhyaya, B M Hibbard, S M Walker.   

Abstract

Two hundred males attending a fertility clinic and 65 men who had fathered one or more children were screened for sperm antibodies using sperm agglutination and immobilisation tests. The incidence of sperm antibodies was significantly higher in the former group. Agglutinin and immobilisin were not related to sperm concentration, morphology, ejaculate volume, seminal plasma zinc, magnesium, acid phosphatase and fructose. However, sperm motility and viability were significantly reduced in the presence of sperm antibodies. There appeared to be no relationship between the presence of antisperm antibodies and Mycoplasma, aerobic or anaerobic organisms. There was a positive correlation between agglutinating and immobilising antibodies in serum and seminal plasma. This study suggests that sperm antibodies at a significant titre may lower male fertility.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6534457     DOI: 10.1111/j.1464-410x.1984.tb06272.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility?

Authors:  M S Cookson; M A Witt; K T Kimball; J E Grantmyre; L I Lipshultz
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 2.  Traditional Chinese Medicine as a Remedy for Male Infertility: A Review.

Authors:  Shao Hu Zhou; Yu Fei Deng; Zhi Wei Weng; Hao Wei Weng; Zhi Dan Liu
Journal:  World J Mens Health       Date:  2019-01-10       Impact factor: 5.400

Review 3.  Efficacy and Safety of Traditional Chinese Medicine in the Treatment of Immune Infertility Based on the Theory of "Kidney Deficiency and Blood Stasis": A Systematic Review and Meta-Analysis.

Authors:  Yi-Ling Bai; Yun-Hui Chen; Cui Jiang; Jun-Hui Qian; Ling-Ling Han; Hai-Zhen Lu; Hao-Zhong Wang; Yi-Rong Sun
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-15       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.